Two calix[4]pyrroles As Potential Therapeutics for Castration-Resistant Prostate Cancer

The authors conducted pre-clinical in vitro and in vivo studies and reported that calixpyrrole derivatives can inhibit cell growth in both PC3 and DU145 prostatic cancer cell lines.